129 related articles for article (PubMed ID: 4606)
1. Vasoconstrictor actions of delta8- and delta9-tetrahydrocannabinol in the rat.
Adams MD; Earnhardt JT; Dewey WL; Harris LS
J Pharmacol Exp Ther; 1976 Mar; 196(3):649-56. PubMed ID: 4606
[TBL] [Abstract][Full Text] [Related]
2. Autonomic and cardiovascular effects of chronic delta9-tetrahydrocannabinol administration in mongrel dogs.
Jandhyala BS; Buckley JP
Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):593-607. PubMed ID: 193167
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular and respiratory effects of cannabis in cat and rat.
Graham JD; Li DM
Br J Pharmacol; 1973 Sep; 49(1):1-10. PubMed ID: 4787563
[TBL] [Abstract][Full Text] [Related]
4. Effects of cannabinoids on the perfused rat heart.
Smiley KA; Karler R; Turkanis SA
Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):659-75. PubMed ID: 959665
[TBL] [Abstract][Full Text] [Related]
5. Aminotetralin analogs of methoxamine as potential hypertensive agents.
Sharabi FM; Long JP; Rusterholz DB; Barfknecht CF
Res Commun Chem Pathol Pharmacol; 1978 Jan; 19(1):37-55. PubMed ID: 625593
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive effects of delta9-tetrahydrocannabinol.
Kosersky DS
Arch Int Pharmacodyn Ther; 1978 May; 233(1):76-81. PubMed ID: 686909
[TBL] [Abstract][Full Text] [Related]
7. Long-retained metabolites of delta9- and delta8-tetrahydrocannabinols identified as novel fatty acid conjugates.
Leighty EG; Fentiman AF; Foltz RL
Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):13-28. PubMed ID: 935647
[TBL] [Abstract][Full Text] [Related]
8. Further characterization of the time-dependent vascular effects of delta9-tetrahydrocannabinol.
O'Sullivan SE; Kendall DA; Randall MD
J Pharmacol Exp Ther; 2006 Apr; 317(1):428-38. PubMed ID: 16352700
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol.
Lemberger L; Martz R; Rodda B; Forney R; Rowe H
J Clin Invest; 1973 Oct; 52(10):2411-7. PubMed ID: 4729039
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic administration of delta9-tetrahydrocannabinol on the heart rate of mongrel dogs.
Jandhyala BS; Malloy KP; Buckley JP
Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):201-4. PubMed ID: 935652
[TBL] [Abstract][Full Text] [Related]
11. Interaction of adrenergic antagonists with prostaglandin E2 and tetrahydrocannabinol in the eye.
Green K; Kim K
Invest Ophthalmol; 1976 Feb; 15(2):102-11. PubMed ID: 1356
[TBL] [Abstract][Full Text] [Related]
12. [Action of delta 9 tetrahydrocannabinol on the central cardiovascular regulation : mechanism and localization].
Daskalopoulos N; Schmitt H; Laubie M
Encephale; 1975; 1(2):121-32. PubMed ID: 240671
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.
Lake KD; Compton DR; Varga K; Martin BR; Kunos G
J Pharmacol Exp Ther; 1997 Jun; 281(3):1030-7. PubMed ID: 9190833
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
Tarpey SB; Bennett T; Randall MD; Gardiner SM
Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
[TBL] [Abstract][Full Text] [Related]
15. Marihuana-like activity of new synthetic tetrahydrocannabinols.
Martin BR; Dewey WL; Harris LS; Beckner J
Pharmacol Biochem Behav; 1975; 3(5):849-53. PubMed ID: 1208625
[TBL] [Abstract][Full Text] [Related]
16. Differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated vasoconstrictor responses by a vasodilator peptide, urotensin I: comparison with nifedipine.
Bolt GR; Itoh H; Lederis K; MacCannell KL
J Pharmacol Exp Ther; 1989 Dec; 251(3):1147-54. PubMed ID: 2574741
[TBL] [Abstract][Full Text] [Related]
17. Intravenous delta9-Tetrahydrocannabinol: Effects of ventilatory control and cardiovascular dynamics.
Malit LA; Johnstone RE; Bourke DI; Kulp RA; Klein V; Smith TC
Anesthesiology; 1975 Jun; 42(6):666-73. PubMed ID: 1130738
[TBL] [Abstract][Full Text] [Related]
18. Acute and subchronic influences of tetrahydrocannabinols on water and food intake, body weight, and temperature in rats.
Johansson JO; Jarbe TU; Henriksson BG
TIT J Life Sci; 1975; 5(1-2):17-27. PubMed ID: 1188935
[TBL] [Abstract][Full Text] [Related]
19. Tolerance development to the effect of delta9-tetrahydrocannabinol on conditioned behavior: role of treatment interval and influence of microsomal metabolism.
Davis WM; Borgen LA
Arch Int Pharmacodyn Ther; 1975 Jan; 213(1):97-112. PubMed ID: 1156021
[TBL] [Abstract][Full Text] [Related]
20. Pressor responses to ephedrine are mediated by a direct mechanism in the rat.
Liles JT; Dabisch PA; Hude KE; Pradhan L; Varner KJ; Porter JR; Hicks AR; Corll C; Baber SR; Kadowitz PJ
J Pharmacol Exp Ther; 2006 Jan; 316(1):95-105. PubMed ID: 16002460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
